<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-055957</identifier>
<setSpec>1137-6627</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Sleep apnea-hypopnea syndrome and cardiovascular diseases</dc:title>
<dc:description xml:lang="en">Sleep apnea-hypopnea syndrome is characterised    by daytime sleepiness, cognitive-behavioural,    respiratory, cardiac, metabolic or inflammatory    disorders, secondary to repeated obstruction of the    upper airway during sleep. Numerous studies have    shown that SAHS is associated with the presence of    arterial hypertension and the development of    cardiovascular diseases. Similarly, there is an excess of    mortality associated with SAHS. An increase in the    activity of the sympathetic nervous system and    endothelial dysfunction are considered as mediating    mechanisms, together with phenomena of oxidative    stress, platelet aggregation and thrombosis</dc:description>
<dc:creator>Marín, B</dc:creator>
<dc:creator>Fernández, B</dc:creator>
<dc:creator>Domínguez, F. J</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">El síndrome de apnea-hipopnea del sueño se    caracteriza por un cuadro de somnolencia diurna excesiva,    trastornos cognitivos-conductuales, respiratorios,    cardíacos, metabólicos o inflamatorios secundarios    a episodios repetidos de obstrucción de la vía    aérea superior durante el sueño. Numerosos estudios    han demostrado que el SAHS se asocia a la presencia    de hipertensión arterial y al desarrollo de enfermedades    cardiovasculares. Asimismo se acepta un exceso    de mortalidad asociado con el SAHS. Como mecanismos    mediadores se consideran un aumento de actividad    del sistema nervioso simpático, una disfunción    endotelial, junto con fenómenos de estrés oxidativo,    agregación plaquetaria y trombosis</dc:description>
<dc:source>An Sist Sanit Navar;30(supl.1): 89-95, 2007.</dc:source>
<dc:identifier>ibc-055957</dc:identifier>
<dc:title xml:lang="es">Síndrome de apnea-hipopnea del sueño y enfermedad cardiovascular</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d7148^s22012</dc:subject>
<dc:subject>^d34202^s22012</dc:subject>
<dc:subject>^d405^s22012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d7152^s22012</dc:subject>
<dc:subject>^d2359^s22012</dc:subject>
<dc:type>article</dc:type>
<dc:date>200700</dc:date>
</metadata>
</record>
</ibecs-document>
